Literature DB >> 3414551

Myocardial contractility and left ventricular function in obese patients with essential hypertension.

G E Garavaglia1, F H Messerli, B D Nunez, R E Schmieder, E Grossman.   

Abstract

Although the risk of developing congestive heart failure increases in parallel with the degree of obesity, load-dependent indexes of left ventricular function are found to be reduced in patients with morbid obesity only. We used the ratio of end-systolic wall stress to end-systolic volume index, which is load-independent, to assess myocardial contractility in 23 nonobese, 28 mildly obese and 26 moderately obese patients with mild to moderate essential hypertension. Although load-dependent indexes (i.e., ejection fraction, fractional fiber shortening and velocity of circumferential fiber shortening) were similar in the 3 groups, end-systolic wall stress to end-systolic volume index was lower in the moderately obese group (2.63 +/- 0.4, p less than 0.002) and even in the mildly obese group (2.88 +/- 0.8, p less than 0.05) than in the nonobese group (3.27 +/- 0.7). Further, there was a significant inverse relation between end-systolic wall stress to end-systolic volume index and body mass index (r = -0.34, p less than 0.005), diastolic diameter (r = -0.56, p less than 0.001) and left ventricular mass index (r = -0.55, p less than 0.001). Some obese patients have depressed myocardial contractility when compared with lean patients despite well-preserved pump function.

Entities:  

Mesh:

Year:  1988        PMID: 3414551     DOI: 10.1016/0002-9149(88)90662-5

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  15 in total

Review 1.  Cardiovascular risks in obesity.

Authors:  E C Uchegbu; P G Kopelman
Journal:  J Endocrinol Invest       Date:  2002-11       Impact factor: 4.256

Review 2.  Regression of increased left ventricular mass by antihypertensives.

Authors:  C J Lavie; H O Ventura; F H Messerli
Journal:  Drugs       Date:  1991-12       Impact factor: 9.546

Review 3.  Cardiovascular consequences of metabolic syndrome.

Authors:  Johnathan D Tune; Adam G Goodwill; Daniel J Sassoon; Kieren J Mather
Journal:  Transl Res       Date:  2017-01-09       Impact factor: 7.012

4.  Cardiovascular responses to a glucose drink in young male individuals with overweight/obesity and mild alterations in glucose metabolism, but without impaired glucose tolerance.

Authors:  Cathriona R Monnard; Erik Konrad Grasser
Journal:  Eur J Nutr       Date:  2019-10-21       Impact factor: 5.614

Review 5.  Obesity cardiomyopathy and systolic function: obesity is not independently associated with dilated cardiomyopathy.

Authors:  Muhammad Fahad Khan; Mohammad Reza Movahed
Journal:  Heart Fail Rev       Date:  2013-03       Impact factor: 4.214

6.  The classification of obesity disease in logistic regression and neural network methods.

Authors:  Uçman Ergün
Journal:  J Med Syst       Date:  2009-02       Impact factor: 4.460

7.  Obesity and preclinical changes of cardiac geometry and function.

Authors:  Joong Kyung Sung; Jang-Young Kim
Journal:  Korean Circ J       Date:  2010-02-23       Impact factor: 3.243

8.  The examination of the effects of obesity on a number of arteries and body mass index by using expert systems.

Authors:  Firat Hardalaç; Ahmet Tevfik Ozan; Necaattin Barişçi; Uçman Ergün; Selami Serhatlioğlu; Inan Güler
Journal:  J Med Syst       Date:  2004-04       Impact factor: 4.460

9.  Gated single photon emission tomography MIBI stress perfusion imaging for assessing cardiac output and index in obese and non-obese patients.

Authors:  J P Coffey; J C Hill
Journal:  Ir J Med Sci       Date:  2007-11-20       Impact factor: 1.568

Review 10.  Modulation of the endocannabinoid system in cardiovascular disease: therapeutic potential and limitations.

Authors:  Pál Pacher; Partha Mukhopadhyay; Rajesh Mohanraj; Grzegorz Godlewski; Sándor Bátkai; George Kunos
Journal:  Hypertension       Date:  2008-09-08       Impact factor: 10.190

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.